Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -133.43% is in line with its 5-year average of -125.10%, near the high end of its 5-year range (-367.42%–-34.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 34.26% above its 12-month average of -202.96%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -133.43%.
RETURN ON EQUITY (ROE)
-133.43%
RETURN ON EQUITY (ROE) AVG TTM
-202.96%
RETURN ON EQUITY (ROE) AVG 3Y
-169.04%
RETURN ON EQUITY (ROE) AVG 5Y
-125.10%
RETURN ON EQUITY (ROE) AVG 10Y
-119.65%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+34.26%
CURRENT VS 3Y AVG
+21.06%
CURRENT VS 5Y AVG
-6.66%
CURRENT VS 10Y AVG
-11.51%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 532 covered companies
CURRENT VS SECTOR MEDIAN
-231.88%
vs the sector median at left
Aethlon Medical, Inc.
Market Cap
$3.28M
Return on Equity (ROE)
-133.43%
TTM Avg
-202.96%
3Y Avg
-169.04%
5Y Avg
-125.10%
Market Cap
$3.30M
Return on Equity (ROE)
-141.90%
TTM Avg
-194.17%
3Y Avg
-143.89%
5Y Avg
-113.05%
Market Cap
$3.25M
Return on Equity (ROE)
-282.13%
TTM Avg
-313.25%
3Y Avg
-153.55%
5Y Avg
-153.55%
Market Cap
$3.17M
Return on Equity (ROE)
120.45%
TTM Avg
927.43%
3Y Avg
433.61%
5Y Avg
340.10%
Market Cap
$3.46M
Return on Equity (ROE)
-89.85%
TTM Avg
30.83%
3Y Avg
-183.24%
5Y Avg
-146.59%
Market Cap
$3.49M
Return on Equity (ROE)
-591.60%
TTM Avg
-213.16%
3Y Avg
-150.57%
5Y Avg
-4.48%
Market Cap
$3.49M
Return on Equity (ROE)
-40.20%
TTM Avg
193.27%
3Y Avg
-10433.46%
5Y Avg
-6975.64%
Market Cap
$3.40M
Return on Equity (ROE)
N/A
TTM Avg
5741.84%
3Y Avg
2797.55%
5Y Avg
1847.94%
Market Cap
$2.94M
Return on Equity (ROE)
-365.43%
TTM Avg
-2048.73%
3Y Avg
-1082.52%
5Y Avg
-614.77%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aethlon Medical, Inc. (AEMD) | $3.28M | -133.43% | -202.96% | -169.04% | -125.10% |
| IceCure Medical Ltd (ICCM)vs › | $3.30M | -141.90% | -194.17% | -143.89% | -113.05% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | -282.13% | -313.25% | -153.55% | -153.55% |
| MBody AI Ltd. (MBAI)vs › | $3.17M | 120.45% | 927.43% | 433.61% | 340.10% |
| Moolec Science S.A. (MLEC)vs › | $3.46M | -89.85% | 30.83% | -183.24% | -146.59% |
| Nexalin Technology, Inc. (NXL)vs › | $3.49M | -591.60% | -213.16% | -150.57% | -4.48% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -40.20% | 193.27% | -10433.46% | -6975.64% |
| Evogene Ltd. (EVGN)vs › | $3.40M | N/A | 5741.84% | 2797.55% | 1847.94% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $2.94M | -365.43% | -2048.73% | -1082.52% | -614.77% |
| Eocene Ltd. (EOCN)vs › | $3.52M | N/A | N/A | N/A | N/A |
ROE
-133.4%
ROA
-111.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -133.43% |
| 2026-03-31 | -146.36% |
| 2025-12-31 | -171.64% |
| 2025-09-30 | -195.94% |
| 2025-06-30 | -367.42% |
| 2025-03-31 | -261.31% |
| 2024-12-31 | -220.54% |
| 2024-09-30 | -187.24% |
| 2024-06-30 | -131.96% |
| 2024-03-31 | -211.71% |
| 2023-12-31 | -160.94% |
| 2023-09-30 | -112.73% |
| 2023-06-30 | -94.64% |
| 2023-03-31 | -79.86% |
| 2022-12-31 | -77.25% |
| 2022-09-30 | -65.55% |
| 2022-06-30 | -74.52% |
| 2022-03-31 | -60.80% |
| 2021-12-31 | -42.97% |
| 2021-09-30 | -38.24% |
| 2021-06-30 | -34.47% |
| 2021-03-31 | -83.63% |
| 2020-12-31 | -64.02% |
| 2020-09-30 | -42.21% |
| 2020-06-30 | -37.32% |
| 2020-03-31 | -67.74% |
| 2019-12-31 | -158.44% |
| 2019-06-30 | -621.30% |
| 2019-03-31 | -255.41% |
| 2018-12-31 | -178.34% |
| 2018-09-30 | -122.90% |
| 2018-06-30 | -95.51% |
| 2018-03-31 | -92.60% |
| 2017-12-31 | -128.73% |
| 2016-03-31 | -313.84% |
| 2015-12-31 | -164.10% |
| 2015-09-30 | -124.19% |
| 2015-06-30 | -88.02% |
